Maria Andrews, MD
Family Medicine · Tallahassee, FLNPI 1447787684
Payments from drug & device makers
Across 81 payments — averaging $18.53 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Pfizer$410
- Novo Nordisk$153
- AbbVie$153
- Exact Sciences$83
- Boehringer Ingelheim$76
- AstraZeneca$72
- plus $554 from 20 others
What the payments were for
- Food & beverage$1,501100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Pfizer | 26 | $410 |
| Novo Nordisk | 8 | $153 |
| AbbVie | 7 | $153 |
| Exact Sciences | 5 | $83 |
| Boehringer Ingelheim | 3 | $76 |
| AstraZeneca(2 entities) | 3 | $72 |
| Sanofi-aventis U.S. LLC | 3 | $70 |
| Amgen | 4 | $68 |
| Merck | 3 | $49 |
| Vertex | 2 | $49 |
| Novartis | 2 | $45 |
| Phathom Pharmaceuticals, Inc. | 1 | $33 |
| GSK | 1 | $25 |
| Eisai Inc. | 1 | $25 |
| Bayer | 1 | $20 |
| Global Blood Therapeutics, Inc. | 1 | $20 |
| Mylan Specialty L.p. | 1 | $18 |
| Abbott | 1 | $17 |
| Cvrx, Inc. | 1 | $16 |
| Johnson & Johnson | 1 | $15 |
| Shionogi Inc | 1 | $15 |
| Philips North America LLC | 1 | $15 |
| Astellas Pharma US Inc | 1 | $15 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 1 | $14 |
| Mallinckrodt Hospital Products Inc. | 1 | $13 |
| E.r. Squibb & Sons, L.L.C. | 1 | $13 |
How this compares
$1,501 in reported general payments places this provider in the 70th percentile of 7,282 family medicine providers in Florida.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Atorvastatin Calcium | 53 | $865 |
| Valsartan | 14 | $436 |
| Omeprazole | 24 | $392 |
| Levothyroxine Sodium | 36 | $390 |
| Rosuvastatin Calcium | 15 | $385 |
| Lisinopril | 23 | $335 |
| Venlafaxine Hcl | 12 | $281 |
| Metformin Hcl | 22 | $254 |
| Pregabalin | 14 | $212 |
| Tramadol Hcl | 12 | $179 |
| Sertraline Hcl | 16 | $123 |
| Alprazolam | 11 | $121 |
| Amlodipine Besylate | 16 | $112 |
| Naproxen | 13 | $109 |
| Metformin Hcl ErMetformin Hcl | 18 | $75 |
Paid to pharmacies, not to this prescriber.
Other family medicine in Tallahassee
- Hugh ColemanDaytona Beach$115.5M
- Alexander WhiteDaytona Beach$69.7M
- Ronald SurowitzJupiter$38.3M
- Bruce RankinDeland$36.7M
- Keila HooverMiami$33.7M
- John NardandreaOcala$30.8M
- Jorge CasoMiami$22.6M
- Sharrell CooperPalm Coast$16.9M
- Christopher GallowayMelbourne$15.6M
- Dario AltamiranoHialeah$15.5M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.